Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America.

[1]  D. Graham,et al.  Atrophic gastritis in young children and adolescents , 2005, Journal of Clinical Pathology.

[2]  D. Graham,et al.  Histologic and serum risk markers for noncardia early gastric cancer , 2005, International journal of cancer.

[3]  D. Graham,et al.  The time to eradicate gastric cancer is now , 2005, Gut.

[4]  V. Pasechnikov,et al.  Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: A comparative study , 2005, Scandinavian journal of gastroenterology.

[5]  M. Rugge,et al.  Serological Markers for Gastric Atrophy in Asymptomatic Patients Infected with Helicobacter pylori , 2004, American Journal of Gastroenterology.

[6]  P. Wandzel,et al.  Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. , 2004, Acta gastro-enterologica Belgica.

[7]  T. Hibi,et al.  Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy. , 2004, Hepato-gastroenterology.

[8]  M. Rasmussen,et al.  Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study , 2003, European journal of gastroenterology & hepatology.

[9]  P. Sipponen,et al.  Diagnosis of atrophic gastritis from a serum sample. , 2003, Clinical laboratory.

[10]  M. Rugge,et al.  Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading , 2002, Alimentary pharmacology & therapeutics.

[11]  D. Graham,et al.  Patterns of gastric atrophy in intestinal type gastric carcinoma , 2002, Cancer.

[12]  P. Sipponen,et al.  Atrophic Gastritis Serum Levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control Study , 2002, Scandinavian journal of gastroenterology.

[13]  M A Fujino,et al.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations , 1999, Gut.

[14]  D. Graham,et al.  Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. , 1997, Gastroenterology.

[15]  D. Graham,et al.  Perturbations in Gastric Physiology in Helicobacter pylori Duodenal Ulcer: Are They All Epiphenomena? , 1997, Helicobacter.

[16]  D. Graham.  Helicobacter pylori and perturbations in acid secretion: the end of the beginning. , 1996, Gastroenterology.

[17]  M. Tada,et al.  Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. , 1996, The American journal of gastroenterology.

[18]  T. Kawamoto,et al.  Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens , 1995, Japanese journal of cancer research : Gann.

[19]  S. Yoshida,et al.  Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan , 1995, Japanese journal of cancer research : Gann.

[20]  J. Dunn,et al.  Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. , 1994, Scandinavian journal of gastroenterology.

[21]  K. Ishikawa,et al.  Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer , 1993, Japanese journal of cancer research : Gann.

[22]  Kenji Takahashi,et al.  Serum pepsinogens as a screening test of extensive chronic gastritis , 1987, Gastroenterologia Japonica.

[23]  J. Haapakoski,et al.  Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross‐sectional data , 1985, International journal of cancer.

[24]  K. Kimura,et al.  Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. , 1972, Gastroenterology.

[25]  P. Deyhle,et al.  Pylorokardiale Expansion der Gastritis? (Bioptische und funktionelle Untersuchungen)* , 1969 .

[26]  T. Takemoto,et al.  An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis , 1969 .

[27]  D. Graham,et al.  Helicobacter pylori infection is the primary cause of gastric cancer. , 2000, Journal of gastroenterology.

[28]  T. Xie,et al.  Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study. , 1997, Journal of epidemiology.

[29]  K. Kimura,et al.  Gastritis in the Japanese stomach. , 1996, Scandinavian journal of gastroenterology. Supplement.

[30]  R. M. Huberman,et al.  Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. , 1996, Human pathology.

[31]  I. Samloff,et al.  Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. , 1991, Scandinavian journal of gastroenterology. Supplement.

[32]  P. Sipponen,et al.  Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. , 1991, Scandinavian journal of gastroenterology. Supplement.